Understand How The Antiobesity Market Is Poised To Grow Through 2023-2032
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
As per The Business Research Company’s Antiobesity Global Market Report 2023, the antiobesity market is expected to show significant growth in the forecast period.
Key insights from the antiobesity market forecast include:
- Market Size
The global antiobesity market is expected to grow from $3.11 billion in 2022 to $3.46 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The antiobesity market size is expected to grow to $$5.11 billion in 2027 at a CAGR of 10.2%.
- Major Driver
Obesity is a major public health concern globally. Globally, the prevalence rate of obesity is increasing every year.For instance, in May 2022, according to the World Obesity Atlas, a UK-based obesity organization, globally, it is estimated that more than 1 billion people will be suffering from obesity by 2030. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity, and lack of awareness of the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving the market growth.
View More On The Antiobesity Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report
- Key Trend
The pharmaceutical industry is witnessing an increase in the number of mergers and acquisitions among companies developing drugs for metabolic disorders such as obesity, diabetes, and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market. For instance, Evotec AG and Novo Nordisk entered into a strategic alliance to able to discover and develop drug molecules to treat metabolic disorders including obesity, diabetes, and other associated disorders.
- Largest Region
North America was the largest region in the anti-obesity market in 2022.
- Major Players
Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC., BoehringerIngelheim GmbH, and Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd. and Novo Nordisk A/S.
Request A Sample Of The Global Antiobesity Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=3403&type=smp
Key Antiobesity Market Segments
The global antiobesity market is segmented –
1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
The Antiobesity Global Market Report 2023 provides an in-depth analysis on the antiobesity market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the antiobesity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
View More Related Reports –
Antiemetics And Antinauseants Global Market Report 2023
Gastric Cancer Drugs Global Market Report 2023
Gastrointestinal Devices Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
